Siemens

Enzo said that a USPTO board had denied Siemens' request for a rehearing in proceedings that favored Enzo's patent on direct detection of nucleic acid.

People in the News

Premium

Lee Hartwell, Timothy Yeatman join HTG SAB; Expression Analysis appoints Patrick Hurban and Louis Grant; Siemens' Donal Quinn joins AdvaMed Dx's board

Marine Biochem's enzymes are being used in diagnostic kits sold by Siemens and sample-prep kits being tested by another unnamed company — relationships Marine Biochem hopes will help spark its transition from a B2B vendor to a company that sells research tools directly to end users.

The decision paves the way for Enzo to be issued a patent based on its prior application, and the company plans to "rapidly" develop and market products based on the technology for a wide variety of applications.

The patent office was aiming to determine who invented technology first related to nucleic acid signal amplification.

Patents awarded to Pioneer Hi-Bred, Life Technologies, Siemens, and more.

The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.

The companies will market coagulation diagnostic tests under a global agreement.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.